Ravi Kurukulasuriya
Relay Therapeutics (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Chemical Synthesis and Analysis, Hormonal Regulation and Hypertension, Fluorine in Organic Chemistry, Adrenal and Paraganglionic Tumors
Most-Cited Works
- → 2,2,2-Trifluoroethyl Formate: A Versatile and Selective Reagent for the Formylation of Alcohols, Amines, andN-Hydroxylamines(2001)98 cited
- → Potential Drug Targets and Progress Towards Pharmacologic Inhibition of Hepatic Glucose Production(2003)87 cited
- → Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2(2024)58 cited
- → Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach(2016)52 cited
- → Prospects for Pharmacologic Inhibition of Hepatic Glucose Production(2003)51 cited
- → Synthesis of Purines and Other Fused Imidazoles from Acyclic Amidines and Guanidines(2005)44 cited
- → Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy(2019)44 cited
- → Synthesis and structural activity relationship of 11β-HSD1 inhibitors with novel adamantane replacements(2006)31 cited
- → Biaryl amide glucagon receptor antagonists(2004)29 cited
- → Synthesis and biological evaluation of heterocycle containing adamantane 11β-HSD1 inhibitors(2006)26 cited